| 英文别名 |
Radotinib(IY-5511);Radotinib;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyrazin-2-ylpyrimidin-2-yl)amino]benzamide;supect;IY5511;I284LJY110;4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(pyrazin-2-yl)pyrimidin-2-yl]amino}benzamide;IY5511HCl;Radotinib [INN];GTPL7814;BCP12554;AOB87198;s8134;4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyrazin-2-yl)pyrimidin-2-yl)amino)benzamide;Radoti;4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(2-pyrazinyl)-2-pyrimidinyl]amino]benzamide (ACI);4-Methyl-N-[3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl]-3-(4-(pyrazin-2-yl)pyrimidin-2-ylamino)benzamide;926037-48-1;SCHEMBL3359952;2?,3?,17?-Trihydroxy-7?-6-oxo-5?-androstan;NCGC00390586-01;Radotinib (IY-5511);EX-A1035;CCG-269914;DA-40474;NSC-800989;DTXSID90239069;IY 5511;BDBM50590368;CHEMBL4297524;DTXCID60161560;J-690392;Q15269680;DUPWHXBITIZIKZ-UHFFFAOYSA-N;BENZAMIDE, 4-METHYL-N-(3-(4-METHYL-1H-IMIDAZOL-1-YL)-5-(TRIFLUOROMETHYL)PHENYL)-3-((4-(2-PYRAZINYL)-2-PYRIMIDINYL)AMINO)-;NCGC00481590-01;IY-5511;RADOTINIB [MI];Radotinib (IY-5511)?;4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyrazin-2-ylpyrimidin-2-yl)amino)benzamide;DB12323;SB11083;AS-55884;HY-15728;NSC800989;UNII-I284LJY110;KB-146009;AC-30633;926037-48-1 (free base);MFCD27956910;AKOS026750428;Radotinib; IY-5511;;radotinibum;CS-3547;NS00072859;AKOS032950010;4-Methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-(pyrazin-2-yl)pyrimidin-2-ylamino)benzamide;RADOTINIB [WHO-DD] |
微信公众号
客服
